Another study showed that CTRP3 may effectively reduce the inflammation caused by oxidized LDL in mouse aortic endothelial cells and improve endothelial dysfunction by activating PI3K/Akt/eNOS signaling, which indicates a promising atheroma Sclerotherapy strategy (Chen et al., 2019). The gene discussed is AKT1; the disease is endothelial dysfunction.